What is Claryx?
Claryx operates at the intersection of biotechnology and enterprise software, providing a comprehensive platform for continuous genomic surveillance. The company's proprietary technology enables hospitals to detect, trace, and prevent the spread of infections by analyzing transmission pathways across various environmental reservoirs, including air, wastewater, and high-touch surfaces. By leveraging genomic sequencing and artificial intelligence, Claryx offers actionable insights that allow healthcare providers to proactively manage patient safety and operational risks. This unique value proposition places Claryx at the forefront of the digital health revolution, transforming how institutions approach infection prevention in complex clinical environments.
How much funding has Claryx raised?
Claryx has raised a total of $3.5M across 1 funding round:
Angel/Pre-Seed
$3.5M
Angel/Pre-Seed (2026): $3.5M with participation from Outlander VC, 640 Oxford, Precursor Ventures, Boost VC, Company Ventures, and Mana Ventures
Key Investors in Claryx
Outlander VC
Outlander VC is a venture capital firm that focuses on funding visionary founders and disruptive startups at the earliest stages, aiming to identify and support future unicorns.
640 Oxford
640 Oxford is an early-stage venture capital firm focused on empowering founders who are reindustrializing and transforming legacy industries through innovative technology.
Precursor Ventures
Precursor Ventures is a pre-seed and seed stage venture capital firm that prioritizes investing in people over products, building long-term relationships with founders.
What's next for Claryx?
With this major enterprise-level funding, Claryx is well-positioned to scale its deployment across major hospital networks and accelerate its research and development pipeline. The strategic focus will likely shift toward enhancing the predictive capabilities of its AI models and expanding its environmental sampling footprint. As the company matures, it will likely seek to integrate its surveillance data with existing electronic health record systems, creating a seamless, automated feedback loop for hospital administrators. This growth trajectory suggests that Claryx is moving beyond its initial development phase toward becoming a standard-bearer for infection control technology in the global healthcare market.
See full Claryx company page
